News

PolyTherics has executed a research collaboration deal with Spirogen to develop antibody-drug conjugates (ADCs) for the treatment of cancer. Under the collaboration, the companies will produce ADCs by integrating PolyTherics' proprietary TheraPEG linker technology...

Researchers at the University of Copenhagen have documented a previously unknown biological mechanism in the brain's most important line of defence: the blood-brain barrier. Scientists now know that the barrier helps maintain a delicate balance of glutamate, a...

The Innovative Medicines Initiative has officially announced the construction of an EU-wide public-private partnership, the "European Lead Factory", to combine a comprehensive collection of candidate drug molecules - a Joint European Compound Collection - with an industry-like European...

The Schwartz Center for Compassionate Healthcare, a Boston-based nonprofit dedicated to strengthening the relationship between patients and their healthcare providers, today announced it has received a $500,000 grant from the Amgen Foundation. This grant...

GSK has submitted US and EU regulatory applications seeking approval of a quadrivalent influenza vaccine for the "active immunisation of adults and children from 3 years of age for the prevention of influenza disease caused by influenza virus...

Galapagos NV and Servier, a private research based pharmaceutical company,  have announced the achievemen milestones under their alliance agreement in osteoarthritis. These milestones trigger payments to Galapagos totalling €3.5 million, which will contribute to the company’s 2011 financial results....

Essentialis Inc., a San Diego-based pharmaceutical company focused on the development of breakthrough medicines targeted to the ATP-sensitive potassium channel, has filed two new patent applications expanding the patent portfolio claiming its investigational triglyceride-lowering compound DCCR and new methods...